Notice: This company has been marked as potentially delisted and may not be actively trading. BioTelemetry (BEAT) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestTrends BioTelemetry (NASDAQ:BEAT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.85%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$80,000.30Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$10,381.16 Get BEAT Insider Trade Alerts Want to know when executives and insiders are buying or selling BioTelemetry stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BEAT Insider Buying and Selling by Quarter Remove Ads BioTelemetry Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/14/2025Richard FerrariDirectorBuy29,412$1.70$50,000.40 2/14/2025Tim CruickshankCFOBuy17,647$1.70$29,999.90 9/6/2024Urioste George DeDirectorSell1,674$2.34$3,917.16 8/26/2024Urioste George DeDirectorSell300$2.38$714.00 8/23/2024Urioste George DeDirectorSell2,500$2.30$5,750.00 (Data available from 1/1/2013 forward) BEAT Insider Trading Activity - Frequently Asked Questions Who is on BioTelemetry's Insider Roster? The list of insiders at BioTelemetry includes Richard Ferrari, Tim Cruickshank, and Urioste George De. Learn more on insiders at BEAT. What percentage of BioTelemetry stock is owned by insiders? 20.85% of BioTelemetry stock is owned by insiders. Learn more on BEAT's insider holdings. Which BioTelemetry insiders have been buying company stock? The following insiders have purchased BEAT shares in the last 24 months: Richard Ferrari ($50,000.40), and Tim Cruickshank ($29,999.90). How much insider buying is happening at BioTelemetry? Insiders have purchased a total of 47,059 BEAT shares in the last 24 months for a total of $80,000.30 bought. Which BioTelemetry insiders have been selling company stock? The following insider sold BEAT shares in the last 24 months: Urioste George De ($76,935.54). How much insider selling is happening at BioTelemetry? Insiders have sold a total of 35,019 BioTelemetry shares in the last 24 months for a total of $76,935.54 sold. More Insider Trading Tools from MarketBeat Related Companies Nevro Insider Trades Utah Medical Products Insider Trades Accuray Insider Trades TriSalus Life Sciences Insider Trades Perspective Therapeutics Insider Trades Beauty Health Insider Trades LENSAR Insider Trades Orchestra BioMed Insider Trades InfuSystem Insider Trades KORU Medical Systems Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for Investors This page (NASDAQ:BEAT) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioTelemetry, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioTelemetry With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
